Manufacturer:

Janssen

Name:

DARZALEX FASPRO

Category:

J Code

HCPCS:

J9144

NDC(s):

57894-0503-01,

Primary Type:

Cancer

Route of Administration:

Subcutaneous

About:

DARZALEX FASPRO is a Cancer drug manufactured by Janssen and administered via the Subcutaneous route of administration. The J Code: J9144 is aligned to the drug DARZALEX FASPRO.